This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Guodong Sun: Innovator in Pharmaceutical Chemistry
Introduction
Guodong Sun is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for drug synthesis. With a total of 2 patents to his name, his work is recognized for its potential impact on industrial production.
Latest Patents
One of Guodong Sun's latest patents is focused on a sacubitril intermediate and its preparation method. This invention relates to a sacubitril intermediate that can be synthesized through a deprotection reaction of a compound. The disclosed intermediate serves as a raw material for synthesizing sacubitril, a drug used in treating heart failure. The method is advantageous due to its use of easily obtainable raw materials, a simple preparation process, low cost, and environmentally friendly characteristics, making it highly suitable for industrial production.
Career Highlights
Guodong Sun is currently associated with Sunshine Lake Pharma Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative approaches have contributed to the advancement of drug synthesis techniques, enhancing the efficiency and sustainability of pharmaceutical manufacturing.
Collaborations
Guodong has collaborated with notable colleagues, including Lei Chen and Jiebin Zeng, who share his commitment to advancing pharmaceutical research and development.
Conclusion
Guodong Sun's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the industry. His work not only advances drug synthesis but also promotes environmentally friendly practices in pharmaceutical production.